This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Norwegian Cruise to Post Q1 Earnings: What's in the Cards?
by Zacks Equity Research
NCLH's Q1 performance is likely to have benefited from strength in Europe and Alaska bookings, strategic deployment initiatives and enhanced onboard offerings.
4 Stocks That Boast Remarkable Interest Coverage Ratio
by Sumit Singh
STRL, LRN, BJ & PM's impressive interest coverage ratios highlight that these companies can withstand financial hardships.
Hilton to Post Q1 Earnings: What's in the Cards for the Stock?
by Zacks Equity Research
HLT's Q1 2025 performance is likely to have benefited from robust leisure travel trends, an expanding property footprint and brand partnerships.
Beat the Market the Zacks Way: ProAssurance, Stride, Hershey in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Buy this Soaring, Top-Ranked Tariff-Proof Stock Before Earnings and Hold?
by Benjamin Rains
Stride has surged 35% in 2025 to new all-time highs as Wall Street clamors for its growth and ability to stay out of the tariff war. LRN stock has also more than quadrupled the S&P 500 over the last decade.
CHTR Q1 Earnings Miss, Stock Rise on Modest Y/Y Revenue Growth
by Zacks Equity Research
Charter's first-quarter 2025 results show strong momentum in mobile service revenues. Yet, declines in video and ad sales continue to drag on overall growth.
Bull of the Day: Stride (LRN)
by Jeremy Mullin
Online education leader Stride eyes new highs as Wall Street gets bullish.
Stride and Freshpet have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Stride and Freshpet have been highlighted as Zacks Bull and Bear of the Day.
Comcast's Q1 Earnings Surpass Estimates, Revenues Decline Y/Y
by Zacks Equity Research
CMCSA's first-quarter 2025 results reflect steady growth in Studios and Peacock, offset by a decline in total customer relationships for connectivity & platforms.
IMAX Q1 Earnings Surpass Expectations, Revenues Increase Y/Y
by Zacks Equity Research
IMAX first-quarter 2025 earnings beat estimates, with revenues rising year over year, driven by a record first-quarter box office.
Stride, Inc. (LRN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
K12 (LRN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
These 2 Consumer Discretionary Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Whirlpool (WHR) Q1 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Whirlpool (WHR) delivered earnings and revenue surprises of -3.41% and 1.55%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Why Stride (LRN) Stock Can Reach Higher Highs
by Shaun Pruitt
Added to the Zacks Rank #1 (Strong Buy) list this week, Stride (LRN) stock is standing out near its 52-week high of over $140 a share.
Here is Why Growth Investors Should Buy K12 (LRN) Now
by Zacks Equity Research
K12 (LRN) could produce exceptional returns because of its solid growth attributes.
Will K12 (LRN) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
K12 (LRN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Are Consumer Discretionary Stocks Lagging Stride (LRN) This Year?
by Zacks Equity Research
Here is how K12 (LRN) and Life Time Group Holdings, Inc. (LTH) have performed compared to their sector so far this year.
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Stride, 908 Devices, & Contango are well-poised to gain.
Beat the Market the Zacks Way: Casey's, Stride, McDonald's in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Beat the Market the Zacks Way: Amgen, Stride, Sea Limited in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FYC
Should First Trust Small Cap Core AlphaDEX ETF (FYX) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYX
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Stride Stock is Trading at a Premium Than the Industry: Buy or Fold?
by Sraddha Singha
Does an upbeat fiscal 2025 view, offering virtual educational programs and favorable macro trends justify LRN stock's premium valuation?